New psoriasis drug shows promise for dramatic skin clearance
NCT ID NCT06011733
Summary
This study tested whether an injectable drug called bimekizumab is better than a placebo at clearing skin in adults with moderate to severe plaque psoriasis. It involved 133 Chinese participants who received injections for 16 weeks. Researchers measured how much the psoriasis improved and monitored for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ps0041 20022
Hangzhou, China
-
Ps0041 20023
Beijing, China
-
Ps0041 20117
Guangzhou, China
-
Ps0041 20120
Wuhan, China
-
Ps0041 20136
Tianjin, China
-
Ps0041 20184
Shenzhen, China
-
Ps0041 20193
Hangzhou, China
-
Ps0041 20247
Beijing, China
-
Ps0041 20296
Hangzhou, China
-
Ps0041 20306
Beijing, China
-
Ps0041 20308
Shanghai, China
-
Ps0041 20309
Xi'an, China
-
Ps0041 20310
Ningbo, China
-
Ps0041 20311
Guangzhou, China
-
Ps0041 20312
Jinan, China
-
Ps0041 20313
Guangzhou, China
-
Ps0041 20314
Wuxi, China
-
Ps0041 20318
Jinan, China
Conditions
Explore the condition pages connected to this study.